Healthy volunteers:Taking loading dose (180mg) ticagrelor

2 trials

Sponsors

The First Affiliated Hospital of Zhengzhou University, Institute of Clinical Pharmacology, Central South University

Conditions

Cardiovascular diseaseacute coronary syndromes

Phase 1

Role of OATP1B1 and Its Polymorphisms in Ticagrelor Hepatic Disposition and Platelet Response

Active, not recruitingChiCTR1800015632

The First Affiliated Hospital of Zhengzhou UniversityCardiovascular disease

Start: 2018-04-18Updated: 2018-04-30

Phase 4

Investigation on the effects of PEAR1 pathway genetic polymorphisms on antiplatelet activity of ticagrelor

RecruitingChiCTR-OPN-15006160

Institute of Clinical Pharmacology, Central South Universityacute coronary syndromes

Start: 2014-04-01Updated: 2017-04-18